Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2023

Open Access 03-08-2023 | Paraneoplastic Neurologic Syndrome | Case report

Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report

Authors: Amanuel Hassen Ali, Anna Benterud, Trygve Holmøy, Aija Zuleron Myro

Published in: Journal of Medical Case Reports | Issue 1/2023

Login to get access

Abstract

Background

Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare neurological condition with paraneoplastic etiology in about 20% of cases, usually presenting before or shortly after the oncological diagnosis is established. PERM associated with anti-glycine receptor antibodies is not previously reported in a patient with bladder cancer.

Case presentation

A 72-years-old Caucasian male was admitted with acute onset of dysarthria, dysphagia and trismus three years after initial surgical treatment for bladder cancer. The condition was initially diagnosed as tetanus and treated accordingly, but the diagnosis was reconsidered because of progression despite adequate treatment. Diagnostic workup on readmission revealed lung and paraaortal metastases from bladder cancer and anti-glycine receptor (anti-GlyR) antibodies both in the cerebrospinal fluid and in serum, which supplemented with the clinical presentation led to the diagnosis of PERM, presumably related to bladder cancer. The patient showed improvement and stabilization after treatment with intravenous immunoglobulin and chemotherapy against metastatic bladder cancer.

Conclusion

To the best of our knowledge, this is the first reported case of anti-GlyR antibody positive PERM related to urothelial carcinoma. The symptoms mimicked tetanus, and responded to chemotherapy and immunotherapy.
Literature
1.
go back to reference Hutchinson M, Walters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;16:1291–2.CrossRef Hutchinson M, Walters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology. 2008;16:1291–2.CrossRef
2.
go back to reference Stern WM, Howard R, Chalmers RM, et al. Glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus (PERM): a rare but treatable neurological syndrome. Pract Neurol. 2014;14:123–7.CrossRefPubMed Stern WM, Howard R, Chalmers RM, et al. Glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus (PERM): a rare but treatable neurological syndrome. Pract Neurol. 2014;14:123–7.CrossRefPubMed
3.
go back to reference Dalakas MC, Fujii M, Li M, et al. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001;345(26):1870–6.CrossRefPubMed Dalakas MC, Fujii M, Li M, et al. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001;345(26):1870–6.CrossRefPubMed
4.
go back to reference Crisp SJ, Balint B, Vincent A. Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors. Curr Opin Neurol. 2017;30(3):310–6.CrossRefPubMed Crisp SJ, Balint B, Vincent A. Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors. Curr Opin Neurol. 2017;30(3):310–6.CrossRefPubMed
5.
go back to reference Kyskan K, Chapman K, Mattman A, et al. Antiglycine receptor antibody and encephalomyelitis with rigidity and myclonus (PERM) related to small cell lung cancer. BMJ Case Rep. 2013;2013:BCR2013010027.CrossRefPubMedPubMedCentral Kyskan K, Chapman K, Mattman A, et al. Antiglycine receptor antibody and encephalomyelitis with rigidity and myclonus (PERM) related to small cell lung cancer. BMJ Case Rep. 2013;2013:BCR2013010027.CrossRefPubMedPubMedCentral
6.
go back to reference Su Y, Cui L, Zhu M, et al. Progressive encephalomyelitis with rigidity and myoclonus with Thymoma: a case report and Literature review. Front Neurol. 2020;11:1017.CrossRefPubMedPubMedCentral Su Y, Cui L, Zhu M, et al. Progressive encephalomyelitis with rigidity and myoclonus with Thymoma: a case report and Literature review. Front Neurol. 2020;11:1017.CrossRefPubMedPubMedCentral
8.
go back to reference Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015;86(8):840–8.CrossRefPubMed Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015;86(8):840–8.CrossRefPubMed
9.
go back to reference Chang A, Lin KY, Chuang KJ, et al. Progressive encephalomyelitis with rigidity: a Taiwanese case and review of literature. Clin Neurol Neurosurg. 2021;208: 106807.CrossRefPubMed Chang A, Lin KY, Chuang KJ, et al. Progressive encephalomyelitis with rigidity: a Taiwanese case and review of literature. Clin Neurol Neurosurg. 2021;208: 106807.CrossRefPubMed
12.
go back to reference Blomme L, Van De Velde K. Trismus as a presenting symptom in a case of progressive encephalopathy with rigidity and myoclonus. Case Rep Neurol. 2019;11(1):132–6.CrossRefPubMedPubMedCentral Blomme L, Van De Velde K. Trismus as a presenting symptom in a case of progressive encephalopathy with rigidity and myoclonus. Case Rep Neurol. 2019;11(1):132–6.CrossRefPubMedPubMedCentral
13.
go back to reference Abbatemarco JR, Yan C, Kunchok A, et al. Antibody-mediated autoimmune encephalitis: a practical approach. Clevel Clin J Med. 2021;88(8):459–71.CrossRef Abbatemarco JR, Yan C, Kunchok A, et al. Antibody-mediated autoimmune encephalitis: a practical approach. Clevel Clin J Med. 2021;88(8):459–71.CrossRef
14.
go back to reference Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2009;56(1):303–9.CrossRefPubMed Lynch JW. Native glycine receptor subtypes and their physiological roles. Neuropharmacology. 2009;56(1):303–9.CrossRefPubMed
15.
go back to reference Carvajal-Gonzalez A, Leite MI, Walters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain. 2014;137:2178–92.CrossRefPubMedPubMedCentral Carvajal-Gonzalez A, Leite MI, Walters P, et al. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain. 2014;137:2178–92.CrossRefPubMedPubMedCentral
17.
Metadata
Title
Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report
Authors
Amanuel Hassen Ali
Anna Benterud
Trygve Holmøy
Aija Zuleron Myro
Publication date
03-08-2023

Other articles of this Issue 1/2023

Journal of Medical Case Reports 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine